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CdSe/ZnS core/shell quantum dots (QDs) are used as eﬃcient F¨ orster Resonance Energy Transfer (FRET) acceptors in a time-
resolved immunoassays with Tb complexes as donors providing a long-lived luminescence decay. A detailed decay time analysis
of the FRET process is presented. QD FRET sensitization is evidenced by a more than 1000-fold increase of the QD luminescence
decay time reaching ca. 0.5 milliseconds, the same value to which the Tb donor decay time is quenched due to FRET to the QD
acceptors. The FRET system has an extremely large F¨ orster radius of approx. 100 ˚ A and more than 70% FRET eﬃciency with a
meandonor-acceptordistanceofca.84 ˚ A,conﬁrmingtheappliedbiotin-streptavidinbindingsystem.Time-resolvedmeasurement
allows for suppression of short-lived emission due to background ﬂuorescence and directly excited QDs. By this means a detection
limit of 18 attomol QDs within the immunoassay is accomplished, an improvement of more than two orders of magnitude com-
pared to commercial systems.
Copyright © 2007 Niko Hildebrandt et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
CdSe/ZnS semiconductor nanocrystals or quantum dots
(QDs) possess unrivalled photophysical properties, such as
size tunable emission wavelengths, extremely high extinc-
tion coeﬃcients over a broad absorption spectrum and en-
hanced photostability compared to organic ﬂuorophores [1–
4]. Moreover, several concepts have been introduced in or-
der to develop water soluble and biocompatible QDs [5–9].
Homogeneous F¨ orsterresonanceenergytransfer(FRET)im-
munoassays with QDs as energy acceptors are of particular
interest because of the extremely high-extinction coeﬃcients
of the QDs over a broad absorption spectrum. This special
optical property gives rise to large F¨ orster radii leading to ef-
ﬁcient FRET over long distances [10–12]. However, the use
of QDs as FRET acceptors with organic dye donors is prob-
lematic, probably due to the short-lived emission of these
donors, hence FRET could not be shown for these donor-
acceptor pairs [13]. Only very few publications deal with
QDs as acceptors within the biological context, for example,
by using bioluminescence energy transfer [14, 15], or with
FRET donors of Tb and Eu complexes [16, 17]. In this con-
tribution, we extend these investigations by a thorough anal-
ysis of donor and acceptor luminescence decay times, which
areimportantparametersforunderstandingthedynamicpa-
rameters of the FRET process [11, 18]. Within a ﬂuoroim-
munoassay of a Tb complex streptavidin conjugate and bi-
otinylated QDs, the sensitized QD acceptor as well as the Tb
donor should change their luminescence decay times once
theyarebroughttocloseproximitybythebiotin-streptavidin
binding process. For both QD as well as Tb luminescence de-
cay times, we provide further evidence of eﬃcient QD sensi-
tization by FRET from Tb. Previously reported large F¨ orster
radii, the high FRET eﬃciency, and the assumed biotin-
streptavidin binding model are conﬁrmed. Moreover, taking
advantage of the time-resolved measurement for suppressing2 Journal of Biomedicine and Biotechnology
the short-lived background emission and QD ﬂuorescence
(from directly excited QDs), and optimizing laser excitation
(new laser system with low background emission) and sol-
vent conditions (azide-free solvent leading to decreased lu-
minescence quenching of Tb), a very low detection limit
is obtained. This means that a sensitivity improvement of
more than two orders of magnitude is accomplished, taking
the well established and extensively studied Eu-TBP (Eu3+-
tris(bypyridine) and APC (allophycocyanin) donor-acceptor
system [19–21], used within the same streptavidin-biotin as-
say format, for comparison. The presented results demon-
strate the great potential of the Tb to QD FRET system for
highly sensitive homogeneous immunoassays for biological
as well as clinical and medical applications.
2. MATERIALS AND METHODS
2.1. FRETdonorsandacceptors
The FRET donors are conjugates of the tetrameric protein
streptavidin (Strep) labeled with Tb complexes (TbL), pro-
duced as described in the literature [17, 22]. A labeling ratio
of(10 ± 1)TbLperStrepwasdeterminedbyUV-Visabsorp-
tion spectroscopy [22].
The FRET acceptors are commercially available biotiny-
lated CdSe/ZnS core/shell quantum dot nanocrystals emit-
ting at 655nm (Biot-QD) purchased from Invitrogen Cor-
poration (Carlsbad, Calif, USA). A ratio of ca. 6 biotin
molecules per QD is speciﬁed by the supplier.
Strep has a very high binding aﬃnity towards biotin with
a ﬁrst dissociation constant of the complex of 10−13 M[ 23].
The biological FRET system is obtained by the strong recog-
nition process between biotin and streptavidin leading to a
close proximity of donor and acceptor.
2.2. Fluoroimmunoassay
The ﬂuoroimmunoassay (FIA) was performed by adding in-
creasingamounts(0–150μl)ofBiot-QDstocksolution(con-
centration c = 1·10
−9 M) to a stock of 1·10
−9 MT b L-Strep
(150–0μl) leading to a total assay volume of 150μlf o re a c h
TbL-Strep + Biot-QD mixture. The used solvent was 50mM
boratebuﬀer(pH8.3)with2%bovineserumalbumin(BSA)
and 0.5M potassium ﬂuoride (KF).
The assay was excited at 315nm by a Nd:YAG-OPO laser
system (Nd:YAG-Laser: Spectra-Physics, Mountain View,
Calif, USA; OPO: GWU-Lasertechnik, Erftstadt, Germany)
working at 20Hz repetition rate, with an average pulse en-
ergy of ca. 15μJ, ﬁbre coupled to the ﬂuoroimmunoreader.
The reader system is a commercially available Kryp-
t o ri m m u n o r e a d e r( C e z a n n e ,N ˆ ımes, France) modiﬁed for
315nmexcitationwavelength.Luminescenceintensitieswere
collected at (665 ± 5)nm (channel A – QD emission) and at
(545 ± 5)nm (channel B – Tb emission). Time-resolved de-
tection is performed by single photon counting with 2 mi-
croseconds integration steps over 8 milliseconds using one
photon multiplier tube (PMT) for each channel [22].
2.3. Time-resolvedFRETcalculations
LuminescencedecaycurvesforthediﬀerentmixturesofTbL-
Strep + Biot-QD are collected for both QD (channel A) and
Tb (channel B) luminescence.
Thetime-dependentluminescenceintensityinchannelA
(IA(t)) is the sum of a background emission (due to directly
excited QDs (I(BgQD)), a weak Tb emission (I(BgTb)) oc-
curing from the 5D4→7F2−0 transitions) and the QD emis-
sion arising from Tb to QD energy transfer given by FRET
theory [11]:
IA(t) = a·I(BgQD)+ b·I(BgTb)
+c·exp

−
t
τD
−
t
τD
·

R0
r
6
,
(1)
where τD is the Tb luminescence decay time of pure TbL-
Strep(absenceoftheQDacceptor),R0 istheF¨ orsterradiusof
the donor-acceptor pair, c is the amount of transfered energy
or FRET intensity, and r is the average donor-acceptor dis-
tance. For the decay curves obtained from our experiments,
I(BgQD) is the time-dependent luminescence intensity of
0.1nM pure Biot-QD in channel A, I(BgTb) is the time-
dependent luminescence intensity of 1nM pure TbL-Strep
in channel A, and a and b are correction factors depending
on the actual concentration of Biot-QD and TbL-Strep (in-
cluding donor emission decrease due to FRET) within the
diﬀerent mixtures.
The two variable parameters r and c are ﬁtted (using the
Microsoft Excel Solver option) so that (1) ﬁts the respective
decay function of each TbL-Strep + Biot-QD mixture. This
means that the donor-acceptor distance r and the FRET in-
tensityc aredetermined.Assumingthattheluminescencede-
cay time of pure QDs is very fast compared to the decay time
of the pure Tb donor, the luminescence decay time of QDs
upon FRET sensitization (τAD) is the same as the Tb decay
time in presence of QD (τDA)[ 24]. τAD and τDA can be cal-
culated using:
1
τAD
=
1
τDA
=
1
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+
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.( 2 )
In order to verify the ﬁtting procedure used for chan-
nel A (QD emission channel), a diﬀerent method was used
for channel B, where a simple bi-exponential ﬁt (using the
Origin ﬁt procedure) is performed without using any ﬁxed
parameters. The luminescence decay in this channel (Tb
emission channel) is determined by τD (no FRET) and τDA
(FRET). QD luminescence does not occur in this channel.
The time-dependent luminescence intensity in channel B is
given by:
IB(t) = I0 +x·exp

−
t
τD

+ y·exp

−
t
τDA

,( 3 )
where I0 is an intensity oﬀset and:
 ∞
0
x·exp

−
t
τD

dt = x·τD,
 ∞
0
y·exp

−
t
τDA

dt = y·τDA
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represent the dimensionless luminescence intensities of Tb
in absence and presence of QD, respectively. In this case, the
FRET intensity can be described by y·τDA (increasing with
Biot-QD addition) or by x·τD (decreasing with Biot-QD ad-
dition).
2.4. Immunoassaydetectionlimit
For calculation of the limit of detection (LOD) for Biot-QD
in this type of FIA, the luminescence intensity ratio (RI)o f
channel A and channel B integrated from 0.1 to 1.2 millisec-
onds after the excitation laser pulse (time gating) was used:
RI =
 1.2ms
0.1msIA(t)dt
 1.2ms
0.1msIB(t)dt
.( 5 )
RI is displayed as a function of Biot-QD concentration
forthediﬀerentmixtures ofTbL-Strep+Biot-QDwithinthe
FIA. The linear part of the rising RI over [Biot-QD] is then
used to calculate the LOD by three times the standard devi-
ation of 12 RI values at [Biot-QD] = 0( σ0) devided by the
slope of RI over [Biot-QD]:
LOD = 3·σ0·
Δ[Biot-QD]
ΔRI
.( 6 )
3. RESULTS AND DISCUSSION
3.1. Luminescencedecaytimeanalysis
Besides the pure TbL-Strep stock solution (c = 1·10
−9 M)
and two pure Biot-QD solutions (c = 1·10
−9 Ma n dc =
1·10
−10 M), 13 mixtures of TbL-Strep + Biot-QD with ratios
ranging 0.007–2.0 Biot-QD per TbL-Strep were measured.
Figures 1 and 2 show some representative luminescence as
well as QD background decay curves for the two detection
channels.
Regarding the increasing QD emission in channel A
(Figure 1),FRETsensitizationofQDsbyTbbecomesalready
obvious for low ratios of Biot-QD/TbL-Strep, whereas the
QD emission decreases again for ratios higher than 0.5 due
to the decreasing TbL-Strep donor concentration with Biot-
QD addition (cf. Section 2).
Higher amounts of Biot-QD are necessary for a clearly
visible FRET inﬂuence in the Tb channel B (Figure 2). There
are two reasons for this behavior, the high labeling ratio of
10 TbL per Strep, and the binding of up to six TbL-Strep per
Biot-QD, as suggested in previous publications [16, 17, 22].
This means that Biot-QD is saturatedwith TbL-Strep for low
ratios and there is still a majority of free TbL-Strep in solu-
tion. Hence, the inﬂuence on QD emission is strong whereas
it is negligible for Tb. At higher amounts of Biot-QD in the
assay, Tb emission is quenched due to FRET and a second
decay time becomes obvious in the decay curves.
In order to perform time-resolved FRET calculations us-
ing (1), the F¨ orster radius R0 (in ˚ A) has to be determined by
[11]:
R6
0 = 8.79·10
−5·n−4
r ·ΦTb·κ2·J(λ)( 7 )
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Figure 1: Luminescence decay curves for pure TbL-Strep (c =
1·10
−9 M) and mixtures of TbL-Strep + Biot-QD with ratios be-
tween 0.007 and 2.0 Biot-QD per TbL-Strep measured in channel
A ((665 ± 5)nm). A background decay curve of pure Biot-QD (c
= 1·10
−10 M) arising from a strong detector saturation of short-
lived directly excited QD ﬂuorescence is also displayed. Fits accord-
ing to (1) displayed as thick solid lines.
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Figure 2:Luminescenceandbackgrounddecaycurves(fordescrip-
tion, see Figure 1) measured in channel B ((545 ±5)nm).
with:
J(λ) =

FTb(λ)·εQD(λ)·λ
4dλ,( 8 )
where nr is the refractive index of the surrounding medium
(1.4 for aqueous media [11]), ΦTb is the Tb centered lumi-
nescencequantumyield[25],κ2 isthedipoleorientationfac-
tor (2/3 for randomly oriented systems in solution [11, 25]),
J(λ) is the overlap integral in M−1 cm−1 nm4, FTb is the nor-
malized TbL-Strep luminescence spectrum in nm−1 (with4 Journal of Biomedicine and Biotechnology
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Figure 3: Normalized emission spectrum of TbL-Strep (green) and
extinction coeﬃcient spectrum of Biot-QD (red).

FTb(λ)dλ = 1), and εQD(λ) is the Biot-QD extinction coef-
ﬁcient spectrum in M−1 cm−1. Taking the luminescence de-
cay time (τ0 = 1.48ms) and the quantum yield (Φ0
Tb = 0.49)
of TbL in pure water [26] and the Tb luminescence decay
time of pure TbL-Strep within the assay (τD = 1.83 millisec-
onds), a value of ΦTb = 0.61 can be calculated by [17, 22]:
ΦTb = Φ0
Tb·
τD
τ0 .( 9 )
RegardingtheTbL-Strepluminescencespectrumandthe
Biot-QDextinctioncoeﬃcientspectruminFigure 3,thevery
good overlap becomes obvious, resulting in an extremely
large F¨ orster radius of R0 = (100 ± 2) ˚ A.
Taking this value for ﬁtting r and c in (1)f o re a c hl u m i -
nescencedecay(measuredinchannelA)ofthediﬀerentTbL-
Strep + Biot-QD mixtures leads to a mean donor-acceptor
distance of r = (84 ± 1) ˚ A (in good agreement with the pro-
posed TbL-Strep + Biot-QD binding model [16, 17, 22]) and
an average FRET sensitized QD luminescence decay time of
τAD = (0.47 ± 0.03) milliseconds, which is an increase of
more than three orders of magnitude compared to the lu-
minescence decay times of pure Biot-QD, which are in the
100-nanosecond range [16, 17].
These values lead to a FRET eﬃciency of (74 ± 6)% cal-
culated by [11]:
ηFRET =
R6
0
R6
0 +r6 = 1 −
τAD
τD
. (10)
The calculations of τAD and r could be conﬁrmed
(Figure 4) by ﬁtting the luminescence decay curves of chan-
nel B using (3). Values of τDA = (0.46 ± 0.07) milliseconds
and r = (83 ±3) ˚ A are obtained.
As mentioned above, the inﬂuence of FRET on the emis-
sion signal in channel B starts at higher Biot-QD/TbL-Strep
ratios. Hence, only decay curves for ratios above 0.04 are
taken into account for the calculations.
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Figure 4: Luminescence decay times of Tb and QDs (τDA)d u et o
QD FRET sensitization by Tb and donor-acceptor distances (r) cal-
culated from luminescence decay curves of channel A (black dots)
and channel B (red triangles), respectively. The dashed lines repre-
sent mean values of τDA and r.
Regardingther−6 dependenceofFRET,itcanbeassumed
that mainly donors which are close to the QD acceptor con-
tribute to the measured FRET signals. As the QD lumines-
cencedecayisseveralordersofmagnitudefasterthantheone
of TbL, absorption saturation by direct QD excitation is neg-
ligibleandasingleQDacceptorcaninteractwithseveralTbL
donors. This does not inﬂuence the FRET eﬃciency but lead
to a higher FRET signal intensity which has positive impact
on assay sensitivity. Nevertheless, due to the distribution of
several TbL donors labeled to streptavidin, τAD, r and ηFRET
are average values.
F u r t h e re v i d e n c eo fF R E Tf r o mT bt oQ Di sg i v e nb y
the FRET intensities (c from (1)a n dx·τD as well as y·τDA
from (3)) obtained from ﬁtting the decays of channel A and
B. In order to compare the FRET intensities arising from
the diﬀerent signals, they were normalized to unity at a
Biot-QD/TbL-Strep ratio of 0.25 and the decreasing (FRET
quenched) donor intensity (x·τD) was subtracted from the
concentration-dependent pure TbL-Strep donor signal (Tb
signal in absence of QD). Figure 5 shows the very good cor-
relation of the FRET intensities calculated from the three dif-
ferent signals.
A strong increase is ﬁrst observed, up to the saturation of
the six biotins on the QD surface by TbL-Strep and is fol-
lowed by a decrease due to the reduced donor concentra-
tion in the assay volume. This conﬁrms the strong increase
of FRET up to a ratio of 1/6 Biot-QD/TbL-Strep and the
proposed TbL-Strep + Biot-QD binding model [16, 17, 22].
Moreover, it shows that large QD aggregates bridged by TbL-
Strep are not formed at these low concentrations, as it would
result in a signal increase up to much higher Biot-QD/TbL-
Strep, regarding the number of ten Tb donors per Strep.
For understanding the dynamic parameters of FRET, in-
vestigation of luminescence decay times is of great impor-
tance. This luminescence decay time analysis over a broad
range of Biot-QD/TbL-Strep ratio gives clear evidence ofNiko Hildebrandt et al. 5
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Figure 5: Normalized FRET intensities calculated with (1) and (3)
from sensitized QD emission (red circles), short-lived Tb emission
due to FRET quenching (black squares), and long-lived Tb emis-
sion of unquenched Tb (green triangles). The dotted line indicates
a ratio of 6 TbL-Strep per Biot-QD.
01234
[Biot-QD] (10−10 M)
0
0.2
0.4
0.6
0.8
R
I
Figure 6:IntensityratioRI (cf.(5))overBiot-QDconcentrationfor
the TbL-Strep + Biot-QD immunoassay after 8 hours incubation.
Linear ﬁt for LOD calculation shown as solid line.
FRET from Tb to QD within the homogeneous streptavidin-
biotin immunoassay and conﬁrms the results accomplished
with time-gated emission intensity detection in earlier pub-
lications [16, 17, 22].
3.2. Immunoassaysensitivity
In order to evaluate the sensitivity of the assay, RI (cf. (5)) is
displayed over Biot-QD concentration and the LOD is deter-
mined from the linear part of the rising RI calibration curve
obtained from the diﬀerent TbL-Strep + Biot-QD mixtures
(Figure 6).
The RI function shows excellent linearity up to a con-
centrationof ca. 2·10
−10 MBiot-QD.Thezeroconcentration
standarddeviationhasavalueofσ0 = 0.00013whichleadsto
an LOD of 0.12pM Biot-QD (18 attomol of Biot-QD within
the 150μl assay volume) taking the slope of the linear ﬁt in
Figure 6.
Comparingthisdetectionlimittoearlierresultsusingthe
same assay with azide containing solutions displays an im-
provement of one order of magnitude and an LOD decrease
of more than two orders of magnitude compared to the ho-
mogeneous FRET FIA “gold standard” donor-acceptor pair
of Eu-TBP and APC [21] using the same streptavidin-biotin
assay [17].
These results underline the very high sensitivity of the Tb
toQDFRETsystemtobeusedaspowerfultoolinbiomedical
analysis, with the possibility of applications in long-distance
biological measurements, for example, in high throughput
screening for in vitro diagnostics. However, it has to be taken
into account that real-life immunoassays can be compli-
cated biological systems and intensive optimization of an-
tibody labeling and measuring conditions is required. First
results with good evidence for FRET in a human chorionic
gonadotropin (HCG) assay (e.g., applied as pregnancy test)
demonstrate the feasibility [22]. In order to achieve the de-
tection limits demonstrated here, these real-life assays are
currently under investigation for further optimization.
ACKNOWLEDGMENTS
This research was supported by the European Community
(Speciﬁc targeted research project LSHB-CT-2007-037933),
the German Bundesministerium f¨ ur Wirtschaft und Tech-
nologie(InnoNetprogram16N0225), andtheFrenchCentre
National de la Recherche Scientiﬁque.
REFERENCES
[1] B. O. Dabbousi, J. Rodriguez-Viejo, F. V. Mikulec, et al.,
“(CdSe)ZnScore-shellquantumdots:synthesisandcharacter-
ization of a size series of highly luminescent nanocrystallites,”
Journal of Physical Chemistry B, vol. 101, no. 46, pp. 9463–
9475, 1997.
[2] D. Gerion, F. Pinaud, S. C. Williams, et al., “Synthesis
and properties of biocompatible water-soluble silica-coated
CdSe/ZnS semiconductor quantum dots,” Journal of Physical
Chemistry B, vol. 105, no. 37, pp. 8861–8871, 2001.
[3] M. A. Hines and P. Guyot-Sionnest, “Synthesis and character-
ization of strongly luminescing ZnS-capped CdSe nanocrys-
tals,” Journal of Physical Chemistry, vol. 100, no. 2, pp. 468–
471, 1996.
[4] A. R. Kortan, R. Hull, R. L. Opila, et al., “Nucleation and
growth of CdSe on ZnS quantum crystallite seeds, and vice
versa,ininversemicellemedia,”JournaloftheAmericanChem-
ical Society, vol. 112, no. 4, pp. 1327–1332, 1990.
[5] W. C. W. Chan and S. M. Nie, “Quantum dot bioconjugates
for ultrasensitive nonisotopic detection,” Science, vol. 281,
no. 5385, pp. 2016–2018, 1998.
[6] W. J. Parak, D. Gerion, D. Zanchet, et al., “Conjugation
of DNA to silanized colloidal semiconductor nanocrystalline
quantum dots,” Chemistry of Materials,v o l .1 4 ,n o .5 ,p p .
2113–2119, 2002.
[ 7 ]P .T .T r a n ,E .R .G o l d m a n ,G .P .A n d e r s o n ,J .M .M a u r o ,a n d
H. Mattoussi, “Use of luminescent CdSe-ZnS nanocrystal bio-
conjugatesinquantumdot-basednanosensors,”PhysicaStatus
Solidi (B), vol. 229, no. 1, pp. 427–432, 2002.6 Journal of Biomedicine and Biotechnology
[8] S.P .W ang,N.M amedova,N.A.K otov ,W .Chen,andJ .Studer ,
“Antigen/antibody immunocomplex from CdTe nanoparticle
bioconjugates,” Nano Letters, vol. 2, no. 8, pp. 817–822, 2002.
[9] W. Z. Guo, J. J. Li, Y. A. Wang, and X. G. Peng, “Conju-
gation chemistry and bioapplications of semiconductor box
nanocrystals prepared via dendrimer bridging,” Chemistry of
Materials, vol. 15, no. 16, pp. 3125–3133, 2003.
[10] R. M. Clegg, “Fluorescence resonance energy transfer,” in Flu-
orescenceImaging Spectroscopy and Microscopy,X .F .W a n ga n d
B. Herman, Eds., pp. 179–252, John Wiley & Sons, New York,
NY, USA, 1996.
[11] J. R. Lakowicz, Principles of Fluorescence Spectroscopy,K l u w e r
Academic/Plenum, New York, NY, USA, 2nd edition, 1999.
[12] B. W. van der Meer, G. Coker, and S. Y. S. Chen, Resonance
Energy Transfer: Theory and Data,V C H ,N e wY o r k ,N Y ,U S A ,
1994.
[13] A. R. Clapp, I. L. Medintz, B. R. Fisher, G. P. Anderson, and H.
Mattoussi,“Canluminescentquantumdotsbeeﬃcientenergy
acceptors with organic dye donors?” Journal of the American
Chemical Society, vol. 127, no. 4, pp. 1242–1250, 2005.
[14] M.-K.So,C.J.Xu,A.M.Loening,S.S.Gambhir,andJ.H.Rao,
“Self-illuminating quantum dot conjugates for in vivo imag-
ing,” Nature Biotechnology, vol. 24, no. 3, pp. 339–343, 2006.
[15] Y. Zhang, M.-K. So, A. M. Loening, H. Q. Yao, S. S. Gambhir,
and J. H. Rao, “HaloTag protein-mediated site-speciﬁc con-
jugation of bioluminescent proteins to quantum dots,” Ange-
wandteChemieInternationalEdition,vol.45,no.30,pp.4936–
4940, 2006.
[16] N. Hildebrandt, L. J. Charbonni` ere, M. Beck, R. F. Ziessel, and
H.-G. L¨ ohmannsr¨ oben, “Quantum dots as eﬃcient energy ac-
ceptors in a time-resolved ﬂuoroimmunoassay,” Angewandte
Chemie International Edition, vol. 44, no. 46, pp. 7612–7615,
2005.
[17] L. J. Charbonni` ere, N. Hildebrandt, R. F. Ziessel, and H.-G.
L¨ ohmannsr¨ oben, “Lanthanides to quantum dots resonance
energy transfer in time-resolved ﬂuoro-immunoassays and lu-
minescence microscopy,” Journalof the AmericanChemicalSo-
ciety, vol. 128, no. 39, pp. 12800–12809, 2006.
[18] Th. F¨ orster, “Zwischenmolekulare Energiewanderung und
Fluoreszenz,” Annalen der Physik, vol. 437, no. 1-2, pp. 55–75,
1948.
[19] K. Enomoto, T. Nagasaki, A. Yamauchi, et al., “Development
of high-throughput spermidine synthase activity assay us-
ing homogeneous time-resolved ﬂuorescence,” Analytical Bio-
chemistry, vol. 351, no. 2, pp. 229–240, 2006.
[20] M. Gabourdes, V. Bourgine, G. Mathis, H. Bazin, and B.
Alpha-Bazin, “A homogeneous time-resolved ﬂuorescence
detection of telomerase activity,” Analytical Biochemistry,
vol. 333, no. 1, pp. 105–113, 2004.
[21] G. Mathis, “Rare earth cryptates and homogeneous ﬂuoroim-
munoassays with human sera,” Clinical Chemistry, vol. 39,
no. 9, pp. 1953–1959, 1993.
[22] N. Hildebrandt, “Lanthanides and quantum dots: time-
resolved laser spectroscopy of biochemical F¨ orster resonance
energy transfer (FRET) systems,” Dissertation, Universit¨ at
Potsdam, Potsdam, Germany, 2006.
[23] A. Loosli, U. E. Rusbandi, J. Gradinaru, et al., “(Strept)avidin
as host for biotinylated coordination complexes: stability, chi-
ral discrimination, and cooperativity,” Inorganic Chemistry,
vol. 45, no. 2, pp. 660–668, 2006.
[24] B. Valeur, Molecular Fluorescence: Principles and Applications,
Wiley-VCH, New York, NY, USA, 2002.
[25] M. Xiao and P. R. Selvin, “Quantum yields of luminescent
lanthanide chelates and far-red dyes measured by resonance
energy transfer,” Journal of the American Chemical Society,
vol. 123, no. 29, pp. 7067–7073, 2001.
[26] N. Weibel, L. J. Charbonni` ere, M. Guardigli, A. Roda, and R.
Ziessel, “Engineering of highly luminescent lanthanide tags
suitable for protein labeling and time-resolved luminescence
imaging,” Journal of the American Chemical Society, vol. 126,
no. 15, pp. 4888–4896, 2004.